|This Slide: #99 of 100|
Slide #99. TearLab Corporation — AOA's OcuHub Technology Platform
TearLab Corporation (TEAR)
AOA's OcuHub Technology Platform
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today announced it has signed a non-binding term sheet to purchase the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association ("AOA").
TearLab is an in-vitro diagnostic company. Co. has commercialized a tear testing platform, the TearLab® Osmolarity System that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Co.'s product measures tear film osmolarity for the diagnosis of dry eye disease. The TearLab® Osmolarity System has three components: the TearLab disposable, which is a single-use microfluidic microchip; the TearLab Pen, which is a hand-held device that interfaces with the TearLab disposable; and the TearLab Reader, which is a desktop unit that allows for the docking of the TearLab Pen and provides a quantitative reading for the operator.
Open the TEAR Page at The Online Investor »
Strong Buy (4.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite